UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 29, 2014.
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________________________ to ________________________
Commission file number 1-7685
AVERY DENNISON CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
95-1492269 |
|
|
(State or other jurisdiction of |
(I.R.S. Employer Identification No.) |
|
|
incorporation or organization) |
|
|
|
207 Goode Avenue |
|
|
|
Glendale, California |
91203 |
|
|
(Address of Principal Executive Offices) |
(Zip Code) |
|
Registrants telephone number, including area code: (626) 304-2000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
x Large accelerated filer |
o Accelerated filer |
o Non-accelerated filer |
o Smaller reporting company |
|
(Do not check if a smaller reporting company) |
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Number of shares of $1 par value common stock outstanding as of April 26, 2014: 95,204,864.
AVERY DENNISON CORPORATION
FISCAL FIRST QUARTER 2014 FORM 10-Q QUARTERLY REPORT
The matters discussed in this Quarterly Report contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as aim, anticipate, assume, believe, continue, could, estimate, expect, foresee, guidance, intend, may, might, objective, plan, potential, project, seek, shall, should, target, will, would, or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.
Certain risks and uncertainties are discussed in more detail under Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 28, 2013 and include, but are not limited to, risks and uncertainties relating to the following: fluctuations in demand affecting sales to customers; the financial condition and inventory strategies of customers; changes in customer order patterns; worldwide and local economic conditions; fluctuations in cost and availability of raw materials; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; impact of competitive products and pricing; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; fluctuations in currency exchange rates and other risks associated with foreign operations; integration of acquisitions and completion of potential dispositions; amounts of future dividends and share repurchases; customer and supplier concentrations; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; fluctuations in interest and tax rates; fluctuations in pension, insurance, and employee benefit costs; impact of legal and regulatory proceedings, including with respect to environmental, health and safety; changes in governmental laws and regulations; changes in political conditions; impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.
We believe that the most significant risk factors that could affect our financial performance in the near-term include: (1) the impact of economic conditions on underlying demand for our products; (2) competitors actions, including pricing, expansion in key markets, and product offerings; and (3) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through selling price increases, without a significant loss of volume.
Our forward-looking statements are made only as of the date hereof. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.
Avery Dennison Corporation
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in millions) |
|
March 29, 2014 |
|
December 28, 2013 |
| ||
Assets |
|
|
|
|
| ||
Current assets: |
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
205.1 |
|
$ |
351.6 |
|
Trade accounts receivable, less allowances of $33 and $31.6 at March 29, 2014 and December 28, 2013, respectively |
|
1,086.2 |
|
1,016.5 |
| ||
Inventories, net |
|
547.6 |
|
494.1 |
| ||
Current deferred and refundable income taxes |
|
101.3 |
|
103.4 |
| ||
Assets held for sale |
|
1.3 |
|
1.3 |
| ||
Other current assets |
|
131.5 |
|
124.9 |
| ||
Total current assets |
|
2,073.0 |
|
2,091.8 |
| ||
Property, plant and equipment |
|
2,727.9 |
|
2,700.8 |
| ||
Accumulated depreciation |
|
(1,808.9 |
) |
(1,778.3 |
) | ||
Property, plant and equipment, net |
|
919.0 |
|
922.5 |
| ||
Goodwill |
|
760.0 |
|
751.1 |
| ||
Other intangibles resulting from business acquisitions, net |
|
89.7 |
|
96.0 |
| ||
Non-current deferred income taxes |
|
261.6 |
|
263.4 |
| ||
Other assets |
|
488.0 |
|
485.8 |
| ||
|
|
$ |
4,591.3 |
|
$ |
4,610.6 |
|
Liabilities and Shareholders Equity |
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
| ||
Short-term borrowings and current portion of long-term debt and capital leases |
|
$ |
167.9 |
|
$ |
76.9 |
|
Accounts payable |
|
887.3 |
|
889.5 |
| ||
Current deferred and payable income taxes |
|
35.5 |
|
49.3 |
| ||
Other current liabilities |
|
449.8 |
|
538.4 |
| ||
Total current liabilities |
|
1,540.5 |
|
1,554.1 |
| ||
Long-term debt and capital leases |
|
950.4 |
|
950.6 |
| ||
Long-term retirement benefits and other liabilities |
|
469.1 |
|
476.4 |
| ||
Non-current deferred and payable income taxes |
|
136.3 |
|
137.3 |
| ||
Commitments and contingencies (see Note 15) |
|
|
|
|
| ||
Shareholders equity: |
|
|
|
|
| ||
Common stock, $1 par value per share, authorized 400,000,000 shares at March 29, 2014 and December 28, 2013; issued 124,126,624 shares at March 29, 2014 and December 28, 2013; outstanding 95,734,525 shares and 96,178,411 shares at March 29, 2014 and December 28, 2013, respectively |
|
124.1 |
|
124.1 |
| ||
Capital in excess of par value |
|
803.9 |
|
812.3 |
| ||
Retained earnings |
|
2,051.8 |
|
2,009.1 |
| ||
Treasury stock at cost, 28,392,099 shares and 27,948,213 shares at March 29, 2014 and December 28, 2013, respectively |
|
(1,207.0 |
) |
(1,172.2 |
) | ||
Accumulated other comprehensive loss |
|
(277.8 |
) |
(281.1 |
) | ||
Total shareholders equity |
|
1,495.0 |
|
1,492.2 |
| ||
|
|
$ |
4,591.3 |
|
$ |
4,610.6 |
|
See Notes to Unaudited Condensed Consolidated Financial Statements
Avery Dennison Corporation
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
Three Months Ended |
| ||||
(In millions, except per share amounts) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales |
|
$ |
1,550.1 |
|
$ |
1,498.9 |
|
Cost of products sold |
|
1,142.9 |
|
1,097.2 |
| ||
Gross profit |
|
407.2 |
|
401.7 |
| ||
Marketing, general and administrative expense |
|
296.7 |
|
300.9 |
| ||
Interest expense |
|
15.4 |
|
12.2 |
| ||
Other expense, net |
|
7.3 |
|
7.5 |
| ||
Income from continuing operations before taxes |
|
87.8 |
|
81.1 |
| ||
Provision for income taxes |
|
16.2 |
|
14.3 |
| ||
Income from continuing operations |
|
71.6 |
|
66.8 |
| ||
Loss from discontinued operations, net of tax |
|
(.4 |
) |
(9.0 |
) | ||
Net income |
|
$ |
71.2 |
|
$ |
57.8 |
|
Per share amounts: |
|
|
|
|
| ||
Net income (loss) per common share: |
|
|
|
|
| ||
Continuing operations |
|
$ |
.74 |
|
$ |
.67 |
|
Discontinued operations |
|
|
|
(.09 |
) | ||
Net income per common share |
|
$ |
.74 |
|
$ |
.58 |
|
Net income (loss) per common share, assuming dilution: |
|
|
|
|
| ||
Continuing operations |
|
$ |
.73 |
|
$ |
.66 |
|
Discontinued operations |
|
|
|
(.09 |
) | ||
Net income per common share, assuming dilution |
|
$ |
.73 |
|
$ |
.57 |
|
Dividends per common share |
|
$ |
.29 |
|
$ |
.27 |
|
Average shares outstanding: |
|
|
|
|
| ||
Common shares |
|
96.1 |
|
100.1 |
| ||
Common shares, assuming dilution |
|
98.0 |
|
101.5 |
|
See Notes to Unaudited Condensed Consolidated Financial Statements
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
|
|
Three Months Ended | |||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net income |
|
$ |
71.2 |
|
$ |
57.8 |
|
Other comprehensive income (loss), before tax: |
|
|
|
|
| ||
Foreign currency translation |
|
(.9 |
) |
(18.0 |
) | ||
Pension and other postretirement benefits |
|
5.5 |
|
6.1 |
| ||
Cash flow hedges |
|
(.1 |
) |
.9 |
| ||
Other comprehensive income (loss), before tax |
|
4.5 |
|
(11.0 |
) | ||
Income tax expense related to components of other comprehensive income (loss) |
|
1.2 |
|
2.3 |
| ||
Other comprehensive income (loss), net of tax |
|
3.3 |
|
(13.3 |
) | ||
Total comprehensive income, net of tax |
|
$ |
74.5 |
|
$ |
44.5 |
|
See Notes to Unaudited Condensed Consolidated Financial Statements
Avery Dennison Corporation
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
Three Months Ended | |||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Operating Activities |
|
|
|
|
| ||
Net income |
|
$ |
71.2 |
|
$ |
57.8 |
|
Adjustments to reconcile net income to net cash used in operating activities: |
|
|
|
|
| ||
Depreciation |
|
33.6 |
|
35.0 |
| ||
Amortization |
|
16.4 |
|
16.5 |
| ||
Provision for doubtful accounts and sales returns |
|
7.3 |
|
5.5 |
| ||
Net loss from asset impairments and sale/disposal of assets |
|
.8 |
|
.4 |
| ||
Stock-based compensation |
|
6.0 |
|
9.2 |
| ||
Other non-cash expense and loss |
|
11.8 |
|
14.7 |
| ||
Change in assets and liabilities and other adjustments |
|
(255.1 |
) |
(204.8 |
) | ||
Net cash used in operating activities |
|
(108.0 |
) |
(65.7 |
) | ||
|
|
|
|
|
| ||
Investing Activities |
|
|
|
|
| ||
Purchases of property, plant and equipment |
|
(38.7 |
) |
(22.0 |
) | ||
Purchases of software and other deferred charges |
|
(8.9 |
) |
(7.8 |
) | ||
Proceeds from sale of property, plant and equipment |
|
.1 |
|
.9 |
| ||
Sales of investments, net |
|
.1 |
|
.1 |
| ||
Net cash used in investing activities |
|
(47.4 |
) |
(28.8 |
) | ||
|
|
|
|
|
| ||
Financing Activities |
|
|
|
|
| ||
Net increase in borrowings (maturities of 90 days or less) |
|
90.4 |
|
135.1 |
| ||
Payments of debt (maturities longer than 90 days) |
|
(.4 |
) |
(.3 |
) | ||
Dividends paid |
|
(27.8 |
) |
(27.1 |
) | ||
Share repurchases |
|
(59.2 |
) |
(61.8 |
) | ||
Proceeds from exercise of stock options, net |
|
12.5 |
|
26.4 |
| ||
Other |
|
(3.2 |
) |
(6.2 |
) | ||
Net cash provided by financing activities |
|
12.3 |
|
66.1 |
| ||
|
|
|
|
|
| ||
Effect of foreign currency translation on cash balances |
|
(3.4 |
) |
.7 |
| ||
Decrease in cash and cash equivalents |
|
(146.5 |
) |
(27.7 |
) | ||
Cash and cash equivalents, beginning of year |
|
351.6 |
|
235.4 |
| ||
Cash and cash equivalents, end of period |
|
$ |
205.1 |
|
$ |
207.7 |
|
See Notes to Unaudited Condensed Consolidated Financial Statements
Avery Dennison Corporation
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1. General
The accompanying unaudited Condensed Consolidated Financial Statements include normal recurring adjustments necessary for a fair statement of our interim results. The unaudited Condensed Consolidated Financial Statements and notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and notes thereto in our 2013 Annual Report on Form 10-K, which should be read in conjunction with this Quarterly Report on Form 10-Q.
Fiscal Period
The first quarter of 2014 and 2013 consisted of thirteen-week periods ending March 29, 2014 and March 30, 2013, respectively. The interim results of operations are not necessarily indicative of future results.
Financial Presentation
As discussed further in Note 2, Discontinued Operations and Assets Held for Sale, we have classified the operating results of our former Office and Consumer Products (OCP) and Designed and Engineered Solutions (DES) businesses, together with certain costs associated with their divestiture, as discontinued operations in the unaudited Consolidated Statements of Income for all periods presented. The results of discontinued operations have been excluded from the notes to our unaudited Condensed Consolidated Financial Statements.
Certain prior period amounts have been reclassified to conform to current period presentation.
In the first quarter of 2014, we began reporting Vancive Medical Technologies as a reportable segment. This business was previously reported within a category entitled other specialty converting businesses and was the only business that comprised that category in the prior periods presented. Vancive Medical Technologies manufactures an array of pressure-sensitive adhesive products for surgical, wound care, ostomy, and electromedical applications. See Note 16, Segment Information, for more information.
Note 2. Discontinued Operations and Assets Held for Sale
Discontinued Operations
In July 2013, we completed the sale of our former OCP and DES businesses and entered into an amendment to the purchase agreement, which, among other things, increased the target net working capital amount and amended provisions related to employee matters and indemnification. We continue to be subject to certain indemnification provisions under the terms of the purchase agreement. In addition, the tax liability associated with the sale is subject to completion of tax return filings in the jurisdictions in which the OCP and DES businesses operated.
The results of these discontinued operations and loss on sale were as follows:
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales |
|
$ |
|
|
$ |
161.9 |
|
Loss before taxes, including divestiture-related and restructuring costs |
|
$ |
|
|
$ |
(10.6 |
) |
Benefit from income taxes |
|
|
|
1.6 |
| ||
Loss from discontinued operations, net of tax before loss on sale |
|
|
|
(9.0 |
) | ||
Loss on sale, net of tax benefit of $.3 |
|
(.4 |
) |
|
| ||
Loss from discontinued operations, net of tax |
|
$ |
(.4 |
) |
$ |
(9.0 |
) |
Net sales from continuing operations to discontinued operations were $19.6 million for the three months ended March 30, 2013. These sales have been included in Net sales in the unaudited Consolidated Statements of Income.
Assets Held for Sale
We classified certain properties and equipment that we are in the process of selling as held for sale in the unaudited Condensed Consolidated Balance Sheets at March 29, 2014 and December 28, 2013.
Avery Dennison Corporation
Note 3. Inventories
Net inventories consisted of:
(In millions) |
|
March 29, 2014 |
|
December 28, 2013 |
| ||
Raw materials |
|
$ |
214.8 |
|
$ |
196.3 |
|
Work-in-progress |
|
167.8 |
|
149.0 |
| ||
Finished goods |
|
165.0 |
|
148.8 |
| ||
Inventories, net |
|
$ |
547.6 |
|
$ |
494.1 |
|
Note 4. Goodwill and Other Intangibles Resulting from Business Acquisitions
Goodwill
Changes in the net carrying amount of goodwill for the three months ended March 29, 2014, by reportable segment, were as follows:
(In millions) |
|
Pressure-sensitive |
|
Retail Branding |
|
Total |
| |||
Goodwill as of December 28, 2013 |
|
$ |
334.4 |
|
$ |
416.7 |
|
$ |
751.1 |
|
Acquisition adjustments(1) |
|
.4 |
|
7.0 |
|
7.4 |
| |||
Translation adjustments |
|
1.4 |
|
.1 |
|
1.5 |
| |||
Goodwill as of March 29, 2014 |
|
$ |
336.2 |
|
$ |
423.8 |
|
$ |
760.0 |
|
(1) Acquisition adjustments to deferred taxes related to previous acquisitions. See Note 11, Taxes Based on Income, for more information.
The carrying amounts of goodwill at March 29, 2014 and December 28, 2013 were net of accumulated impairment losses of $820 million, which were reported in the Retail Branding and Information Solutions segment.
There is no goodwill associated with the Vancive Medical Technologies reportable segment.
Indefinite-Lived Intangible Assets
The carrying value of indefinite-lived intangible assets resulting from business acquisitions, consisting of trademarks, was $11 million and $10.9 million at March 29, 2014 and December 28, 2013, respectively.
Finite-Lived Intangible Assets
The following table sets forth our finite-lived intangible assets resulting from business acquisitions at March 29, 2014 and December 28, 2013, which continue to be amortized:
|
|
March 29, 2014 |
|
December 28, 2013 | |||||||||||||||
(In millions) |
|
Gross |
|
Accumulated |
|
Net |
|
Gross |
|
Accumulated |
|
Net |
| ||||||
Customer relationships |
|
$ |
234.1 |
|
$ |
169.9 |
|
$ |
64.2 |
|
$ |
234.1 |
|
$ |
164.6 |
|
$ |
69.5 |
|
Patents and other acquired technology |
|
49.0 |
|
39.4 |
|
9.6 |
|
48.9 |
|
38.3 |
|
10.6 |
| ||||||
Trade names and trademarks |
|
26.4 |
|
22.8 |
|
3.6 |
|
26.2 |
|
22.5 |
|
3.7 |
| ||||||
Other intangibles |
|
12.5 |
|
11.2 |
|
1.3 |
|
12.4 |
|
11.1 |
|
1.3 |
| ||||||
Total |
|
$ |
322.0 |
|
$ |
243.3 |
|
$ |
78.7 |
|
$ |
321.6 |
|
$ |
236.5 |
|
$ |
85.1 |
|
Amortization expense from continuing operations for finite-lived intangible assets resulting from business acquisitions was $6.6 million and $7.5 million for the three months ended March 29, 2014 and March 30, 2013, respectively.
Avery Dennison Corporation
The estimated amortization expense from continuing operations for finite-lived intangible assets resulting from business acquisitions for the remainder of the current fiscal year and each of the next four fiscal years is expected to be as follows:
(In millions) |
|
Estimated |
| |
Remainder of 2014 |
|
$ |
17.7 |
|
2015 |
|
20.9 |
| |
2016 |
|
19.5 |
| |
2017 |
|
9.9 |
| |
2018 |
|
2.5 |
| |
Note 5. Debt
The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities on notes with similar rates, credit ratings, and remaining maturities. The fair value of short-term borrowings, which include commercial paper and short-term lines of credit, approximates carrying value given the short duration of these obligations. The fair value of our total debt was $1.17 billion at March 29, 2014 and $1.06 billion at December 28, 2013. Fair value amounts were determined primarily based on Level 2 inputs.
Our various loan agreements require that we maintain specified financial covenant ratios of total debt and interest expense in relation to certain measures of income. As of March 29, 2014, we were in compliance with our financial covenants.
Note 6. Pension and Other Postretirement Benefits
Defined Benefit Plans
We sponsor a number of defined benefit plans, the benefits under some of which have been frozen, covering eligible employees in the U.S. and certain other countries. Benefits payable to an employee are based primarily on years of service and the employees compensation during the course of his or her employment with us. While we have not expressed any intent to terminate these plans, we may do so at any time, subject to applicable laws and regulations.
We are also obligated to pay unfunded termination indemnity benefits to certain employees outside of the U.S., which are subject to applicable agreements, local laws and regulations. We have not incurred significant costs related to termination indemnity arrangements, and therefore, no related costs are included in the disclosures below.
The following table sets forth the components of net periodic benefit cost (credit), which are recorded in income from continuing operations, for our defined benefit plans:
|
|
Pension Benefits |
|
U.S. Postretirement Health |
| ||||||||||||||
|
|
Three Months Ended |
|
Three Months Ended |
| ||||||||||||||
|
|
March 29, 2014 |
|
March 30, 2013 |
|
March 29, 2014 |
|
March 30, 2013 |
| ||||||||||
(In millions) |
|
U.S. |
|
Intl |
|
U.S. |
|
Intl |
|
|
|
|
| ||||||
Service cost |
|
$ |
.1 |
|
$ |
3.5 |
|
$ |
.1 |
|
$ |
3.1 |
|
$ |
|
|
$ |
|
|
Interest cost |
|
11.0 |
|
6.0 |
|
9.5 |
|
5.8 |
|
|
|
.1 |
| ||||||
Expected return on plan assets |
|
(13.0 |
) |
(6.5 |
) |
(11.7 |
) |
(5.6 |
) |
|
|
|
| ||||||
Recognized net actuarial loss |
|
3.9 |
|
|
|
4.9 |
|
1.5 |
|
.7 |
|
.7 |
| ||||||
Amortization of prior service cost (credit) |
|
.3 |
|
.1 |
|
.1 |
|
.1 |
|
(.8 |
) |
(1.2 |
) | ||||||
Amortization of transition asset |
|
|
|
1.3 |
|
|
|
|
|
|
|
|
| ||||||
Net periodic benefit cost (credit) |
|
$ |
2.3 |
|
$ |
4.4 |
|
$ |
2.9 |
|
$ |
4.9 |
|
$ |
(.1 |
) |
$ |
(.4 |
) |
We make contributions to our defined benefit plans sufficient to meet the minimum funding requirements of applicable laws and regulations, plus additional amounts, if any, we determine to be appropriate. We contributed $1 million and $11.6 million to our U.S. pension plans during the three months ended March 29, 2014 and March 30, 2013, respectively. We contributed $.3 million and $.8 million to our U.S. postretirement health benefit plan during the three months ended March 29, 2014 and March 30, 2013, respectively. We contributed approximately $8 million to our international pension plans during both the three months ended March 29, 2014 and March 30, 2013. All of the contributions made in the first three months of 2014 and 2013 were made to meet minimum funding requirements.
Avery Dennison Corporation
Defined Contribution Plans
We sponsor various defined contribution plans worldwide, with the largest plan being the Avery Dennison Corporation Employee Savings Plan (Savings Plan), a 401(k) plan available to our U.S. employees. We recognized expense from continuing operations of $6 million and $6.6 million during the three months ended March 29, 2014 and March 30, 2013, respectively, related to our employer contributions and employer match of participant contributions to the Savings Plan.
Note 7. Research and Development
Research and development expense from continuing operations was $24.9 million and $23.5 million for the three months ended March 29, 2014 and March 30, 2013, respectively. This expense was included in Marketing, general and administrative expense in the unaudited Consolidated Statements of Income.
Note 8. Long-Term Incentive Compensation
Equity Awards
Stock-based compensation expense from continuing operations was $6 million and $7.9 million for the three months ended March 29, 2014 and March 30, 2013, respectively. This expense was included in Marketing, general and administrative expense in the unaudited Consolidated Statements of Income.
As of March 29, 2014, we had approximately $54 million of unrecognized compensation expense from continuing operations related to unvested stock-based awards, which is expected to be recognized over the remaining weighted-average requisite service period of approximately three years.
Cash Awards
The compensation expense from continuing operations related to cash-based awards was $5.3 million and $2.7 million for the three months ended March 29, 2014 and March 30, 2013, respectively. This expense was included in Marketing, general and administrative expense in the unaudited Consolidated Statements of Income.
Note 9. Cost Reduction Actions
2014 Actions
During the three months ended March 29, 2014, we recorded $7.3 million in restructuring charges related to restructuring actions we initiated in 2014 (2014 Actions), which consisted of severance and related costs for the reduction of approximately 340 positions and asset impairment charges. Approximately 60 employees impacted by our 2014 Actions remained employed with us as of March 29, 2014. We expect payments to be completed and savings to be realized relating to our 2014 Actions by the end of 2015.
2012 Program
In 2013, we recorded $40.3 million in restructuring charges, net of reversals, related to the restructuring program we initiated in 2012 (2012 Program), which consisted of severance and related costs for the reduction of approximately 1,400 positions, lease and other contract cancellation costs, and asset impairment charges. We expect payments related to the 2012 Program to be completed by the end of 2014.
Accruals for severance and related costs and lease and other contract cancellation costs were included in Other current liabilities in the unaudited Condensed Consolidated Balance Sheets. For assets that were not disposed of, impairments were based on the estimated market value of the assets. Restructuring costs were included in Other expense, net in the unaudited Consolidated Statements of Income.
Avery Dennison Corporation
During the three months ended March 29, 2014, restructuring charges and payments were as follows:
(In millions) |
|
Accrual at |
|
Charges |
|
Cash |
|
Non-cash |
|
Foreign |
|
Accrual at |
| ||||||
2014 Actions |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Severance and related costs |
|
$ |
|
|
$ |
7.0 |
|
$ |
(5.4 |
) |
$ |
|
|
$ |
|
|
$ |
1.6 |
|
Asset impairment charges |
|
|
|
.3 |
|
|
|
(.3 |
) |
|
|
|
| ||||||
2012 Program |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Severance and related costs |
|
6.6 |
|
|
|
(4.9 |
) |
|
|
|
|
1.7 |
| ||||||
Lease and other contract cancellation costs |
|
.2 |
|
|
|
|
|
|
|
|
|
.2 |
| ||||||
Total |
|
$ |
6.8 |
|
$ |
7.3 |
|
$ |
(10.3 |
) |
$ |
(.3 |
) |
$ |
|
|
$ |
3.5 |
|
The table below shows the total amount of costs incurred by reportable segment and Corporate in connection with these restructuring actions for the periods shown below. Restructuring costs were included in Other expense, net in the unaudited Consolidated Statements of Income.
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Restructuring costs by reportable segment and Corporate |
|
|
|
|
| ||
Pressure-sensitive Materials |
|
$ |
1.3 |
|
$ |
3.6 |
|
Retail Branding and Information Solutions |
|
6.0 |
|
4.3 |
| ||
Vancive Medical Technologies |
|
|
|
|
| ||
Corporate |
|
|
|
.2 |
| ||
|
|
$ |
7.3 |
|
$ |
8.1 |
|
Note 10. Financial Instruments
We enter into foreign exchange hedge contracts to reduce our risk from exchange rate fluctuations associated with receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. We also enter into futures contracts to hedge certain price fluctuations for a portion of our anticipated domestic purchases of natural gas. The maximum length of time for which we hedge our exposure to the variability in future cash flows for forecasted transactions is 36 months. We may enter into interest rate contracts to help manage our exposure to certain interest rate fluctuations.
As of March 29, 2014, the aggregate U.S. dollar equivalent notional value of our outstanding commodity contracts and foreign exchange contracts was $4.1 million and $1.9 billion, respectively.
We recognize all derivative instruments as either assets or liabilities at fair value in the unaudited Condensed Consolidated Balance Sheets. We designate commodity forward contracts on forecasted purchases of commodities and foreign exchange contracts on forecasted transactions as cash flow hedges and foreign exchange contracts on existing balance sheet items as fair value hedges.
The following table provides the fair value and balance sheet locations of derivatives as of March 29, 2014:
|
|
Asset |
|
|
|
Liability |
|
|
| ||
(In millions) |
|
Balance Sheet Location |
|
Fair Value |
|
Balance Sheet Location |
|
Fair Value |
| ||
Foreign exchange contracts |
|
Other current assets |
|
$ |
9.8 |
|
Other current liabilities |
|
$ |
4.3 |
|
Commodity contracts |
|
Other current assets |
|
.3 |
|
Other current liabilities |
|
|
| ||
|
|
|
|
$ |
10.1 |
|
|
|
$ |
4.3 |
|
| |||||||||||
The following table provides the fair value and balance sheet locations of derivatives as of December 28, 2013: | |||||||||||
|
|
|
|
| |||||||
|
|
Asset |
|
|
|
Liability |
|
|
| ||
(In millions) |
|
Balance Sheet Location |
|
Fair Value |
|
Balance Sheet Location |
|
Fair Value |
| ||
Foreign exchange contracts |
|
Other current assets |
|
$ |
3.1 |
|
Other current liabilities |
|
$ |
4.7 |
|
Commodity contracts |
|
Other current assets |
|
.1 |
|
Other current liabilities |
|
|
| ||
|
|
|
|
$ |
3.2 |
|
|
|
$ |
4.7 |
|
Avery Dennison Corporation
Fair Value Hedges
For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings, resulting in no net material impact to income.
The following table provides the components of gain (loss) recognized in income related to fair value hedge contracts. The corresponding gains or losses on the underlying hedged items approximated the net gain (loss) on these fair value hedge contracts.
|
|
|
|
Three Months Ended |
| ||||
(In millions) |
|
Location of Gain (Loss) in Income |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Foreign exchange contracts |
|
Cost of products sold |
|
$ |
(.9 |
) |
$ |
(1.1 |
) |
Foreign exchange contracts |
|
Marketing, general and administrative expense |
|
1.0 |
|
(6.9 |
) | ||
|
|
|
|
$ |
.1 |
|
$ |
(8.0 |
) |
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of Accumulated other comprehensive loss and reclassified into earnings in the same period(s) during which the hedged transaction affects earnings. Gains and losses on the derivative, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in current earnings.
Gains (losses) recognized in Accumulated other comprehensive loss (effective portion) on derivatives related to cash flow hedge contracts were as follows:
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Foreign exchange contracts |
|
$ |
(.3 |
) |
$ |
.3 |
|
Commodity contracts |
|
.4 |
|
.3 |
| ||
|
|
$ |
.1 |
|
$ |
.6 |
|
The amounts of gain or loss recognized in income related to the ineffective portion of, and the amounts excluded from, effectiveness testing for cash flow hedges and derivatives not designated as hedging instruments were not material for the three months ended March 29, 2014 and March 30, 2013, respectively.
As of March 29, 2014, we expected a net gain of $.1 million to be reclassified from Accumulated other comprehensive loss to earnings within the next 12 months. See Note 13, Comprehensive Income, for more information.
Note 11. Taxes Based on Income
The following table summarizes our income from continuing operations before taxes, provision for income taxes from continuing operations, and effective tax rate:
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Income from continuing operations before taxes |
|
$ |
87.8 |
|
$ |
81.1 |
|
Provision for income taxes |
|
16.2 |
|
14.3 |
| ||
Effective tax rate |
|
18.4 |
% |
17.6 |
% | ||
The effective tax rate for the three months ended March 29, 2014 included a discrete tax benefit of $9.5 million as a result of changes in certain tax reserves and valuation allowances and a $4.8 million benefit from out-of-period adjustments to properly state deferred taxes related to acquisitions completed in 2002 and 2003. The effective tax rate for the three months ended March 30, 2013 reflected discrete tax benefits of $10.3 million related to changes in tax law, including a $4.2 million benefit attributable to the retroactive reinstatement of the federal research and development tax credit and a $5.1 million benefit for revaluation of deferred tax balances due to a change in the municipal statutory tax rate in Luxembourg.
The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of relevant risks, facts, and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. With some exceptions, we and our subsidiaries are no longer subject to income tax examinations by tax authorities for years prior to 2006.
Avery Dennison Corporation
It is reasonably possible that, during the next 12 months, we may realize a decrease in our uncertain tax positions, including interest and penalties, of approximately $19 million, primarily as a result of closing tax years.
Note 12. Net Income Per Share
Net income per common share was computed as follows:
|
|
Three Months Ended |
| |||||
(In millions, except per share amounts) |
|
March 29, 2014 |
|
March 30, 2013 |
| |||
(A) |
Income from continuing operations |
|
$ |
71.6 |
|
$ |
66.8 |
|
(B) |
Loss from discontinued operations, net of tax |
|
(.4 |
) |
(9.0 |
) | ||
(C) |
Net income available to common shareholders |
|
$ |
71.2 |
|
$ |
57.8 |
|
(D) |
Weighted-average number of common shares outstanding |
|
96.1 |
|
100.1 |
| ||
|
Dilutive shares (additional common shares issuable under employee stock-based awards) |
|
1.9 |
|
1.4 |
| ||
(E) |
Weighted-average number of common shares outstanding, assuming dilution |
|
98.0 |
|
101.5 |
| ||
Net income (loss) per common share: |
|
|
|
|
| |||
Continuing operations (A) ÷ (D) |
|
$ |
.74 |
|
$ |
.67 |
| |
Discontinued operations (B) ÷ (D) |
|
|
|
(.09 |
) | |||
Net income per common share (C) ÷ (D) |
|
$ |
.74 |
|
$ |
.58 |
| |
Net income (loss) per common share, assuming dilution: |
|
|
|
|
| |||
Continuing operations (A) ÷ (E) |
|
$ |
.73 |
|
$ |
.66 |
| |
Discontinued operations (B) ÷ (E) |
|
|
|
(.09 |
) | |||
Net income per common share, assuming dilution (C) ÷ (E) |
|
$ |
.73 |
|
$ |
.57 |
|
Certain stock-based compensation awards were not included in the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled approximately 4 million shares and 7 million shares for the three months ended March 29, 2014 and March 30, 2013, respectively.
Note 13. Comprehensive Income
The changes in Accumulated other comprehensive loss (net of tax) for the three-month period ended March 29, 2014 were as follows:
(In millions) |
|
Cash Flow |
|
Pension and |
|
Foreign |
|
Total |
| ||||
Balance as of December 28, 2013 |
|
$ |
(1.0 |
) |
$ |
(418.1 |
) |
$ |
138.0 |
|
$ |
(281.1 |
) |
Other comprehensive (loss) before reclassifications, net of tax |
|
|
|
|
|
(.9 |
) |
(.9 |
) | ||||
Reclassifications to net income, net of tax |
|
(.1 |
) |
4.3 |
|
|
|
4.2 |
| ||||
Net current-period other comprehensive (loss) income, net of tax |
|
(.1 |
) |
4.3 |
|
(.9 |
) |
3.3 |
| ||||
Balance as of March 29, 2014 |
|
$ |
(1.1 |
) |
$ |
(413.8 |
) |
$ |
137.1 |
|
$ |
(277.8 |
) |
Avery Dennison Corporation
The changes in Accumulated other comprehensive loss (net of tax) for the three-month period ended March 30, 2013 were as follows:
(In millions) |
|
Cash Flow |
|
Pension and |
|
Foreign |
|
Total |
| ||||
Balance as of December 29, 2012 |
|
$ |
(2.0 |
) |
$ |
(456.5 |
) |
$ |
180.5 |
|
$ |
(278.0 |
) |
Other comprehensive income (loss) before reclassifications, net of tax |
|
.6 |
|
|
|
(18.0 |
) |
(17.4 |
) | ||||
Reclassifications to net income, net of tax |
|
|
|
4.1 |
|
|
|
4.1 |
| ||||
Net current-period other comprehensive income (loss), net of tax |
|
.6 |
|
4.1 |
|
(18.0 |
) |
(13.3 |
) | ||||
Balance as of March 30, 2013 |
|
$ |
(1.4 |
) |
$ |
(452.4 |
) |
$ |
162.5 |
|
$ |
(291.3 |
) |
The effects of amounts reclassified from Accumulated other comprehensive loss to income from continuing operations were as follows:
|
|
Amounts Reclassified from Accumulated |
|
|
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
|
Affected Line Item in the |
| ||
Cash flow hedges: |
|
|
|
|
|
|
| ||
Foreign exchange contracts |
|
$ |
|
|
$ |
.5 |
|
Cost of products sold |
|
Commodity contracts |
|
.1 |
|
(.5 |
) |
Cost of products sold |
| ||
|
|
.1 |
|
|
|
Total before tax |
| ||
|
|
|
|
|
|
Income tax expense |
| ||
|
|
.1 |
|
|
|
Net of tax |
| ||
|
|
|
|
|
|
|
| ||
Pension and other postretirement benefits (1) |
|
(5.5 |
) |
(6.1 |
) |
|
| ||
|
|
1.2 |
|
2.0 |
|
Income tax expense |
| ||
|
|
(4.3 |
) |
(4.1 |
) |
Net of tax |
| ||
Total reclassifications for the period |
|
$ |
(4.2 |
) |
$ |
(4.1 |
) |
Total, net of tax |
|
(1) See Note 6, Pension and Other Postretirement Benefits, for more information.
The following table sets forth the tax expense allocated to each component of other comprehensive (loss) income:
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Pension and other postretirement benefits |
|
$ |
1.2 |
|
$ |
2.0 |
|
Cash flow hedges |
|
|
|
.3 |
| ||
Income tax expense related to components of other comprehensive income (loss) |
|
$ |
1.2 |
|
$ |
2.3 |
|
Avery Dennison Corporation
Note 14. Fair Value Measurements
Recurring Fair Value Measurements
The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of March 29, 2014:
|
|
|
|
Fair Value Measurements Using |
| ||||||||
(In millions) |
|
Total |
|
Quoted Prices in |
|
Significant Other |
|
Significant Other |
| ||||
Assets |
|
|
|
|
|
|
|
|
| ||||
Trading securities |
|
$ |
17.8 |
|
$ |
7.6 |
|
$ |
10.2 |
|
$ |
|
|
Derivative assets |
|
10.1 |
|
.3 |
|
9.8 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Liabilities |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilities |
|
$ |
4.3 |
|
$ |
|
|
$ |
4.3 |
|
$ |
|
|
The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of December 28, 2013:
|
|
|
|
Fair Value Measurements Using |
| ||||||||
(In millions) |
|
Total |
|
Quoted Prices in |
|
Significant Other |
|
Significant Other |
| ||||
Assets |
|
|
|
|
|
|
|
|
| ||||
Trading securities |
|
$ |
17.7 |
|
$ |
7.6 |
|
$ |
10.1 |
|
$ |
|
|
Short-term investments |
|
114.5 |
|
|
|
114.5 |
|
|
| ||||
Derivative assets |
|
3.2 |
|
.1 |
|
3.1 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Liabilities |
|
|
|
|
|
|
|
|
| ||||
Derivative liabilities |
|
$ |
4.7 |
|
$ |
|
|
$ |
4.7 |
|
$ |
|
|
Trading securities include fixed income securities (primarily U.S. government and corporate debt securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value. As of March 29, 2014, trading securities of $.4 million and $17.4 million were included in Cash and cash equivalents and Other current assets, respectively, in the unaudited Condensed Consolidated Balance Sheets. As of December 28, 2013, trading securities of $.3 million and $17.4 million were included in Cash and cash equivalents and Other current assets, respectively, in the unaudited Condensed Consolidated Balance Sheets. Short-term investments are comprised of commercial paper and are measured at fair value using broker quoted prices. As of December 28, 2013, short-term investments were included in Cash and cash equivalents in the unaudited Condensed Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy. Derivatives measured based on inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy.
Note 15. Commitments and Contingencies
Legal Proceedings
We are involved in various lawsuits, claims, inquiries, and other regulatory and compliance matters, most of which are routine to the nature of our business. We have accrued liabilities for matters where it is probable that a loss will be incurred and the amount of loss can be reasonably estimated. Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve these matters could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information becomes available that allows us to reasonably estimate the range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries, and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters will be assessed as they arise; until then, a range of potential expenses for such resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of these matters would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.
Environmental
As of March 29, 2014, we have been designated by the U.S. Environmental Protection Agency (EPA) and/or other responsible state agencies as a potentially responsible party (PRP) at ten waste disposal or waste recycling sites, which are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination and for which no settlement of our liability has been agreed. We are participating with other PRPs at these sites, and anticipate that our share of remediation costs will be determined pursuant to agreements entered into in the normal course of negotiations with the EPA or other governmental authorities.
Avery Dennison Corporation
We have accrued liabilities for sites where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, and the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, future expenses to remediate these sites could be higher than the liabilities we have accrued; however, we are unable to reasonably estimate a range of potential expenses. If information becomes available that allows us to reasonably estimate the range of potential expenses in an amount higher or lower than what we have accrued, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites will be addressed as they arise; until then, a range of expenses for such remediation cannot be determined.
The activity for the three months ended March 29, 2014 related to environmental liabilities was as follows:
(In millions) |
|
|
| |
Balance at December 28, 2013 |
|
$ |
29.6 |
|
Charges (reversals), net |
|
(.9 |
) | |
Payments |
|
(1.2 |
) | |
Balance at March 29, 2014 |
|
$ |
27.5 |
|
As of March 29, 2014, approximately $10 million of the balance was classified as short-term and was included in Other current liabilities in the unaudited Condensed Consolidated Balance Sheets.
Guarantees
We participate in receivable financing programs with several financial institutions whereby advances may be requested from these financial institutions. We guarantee the collection of the related receivables. At March 29, 2014, the outstanding amount guaranteed was approximately $5 million.
Unused letters of credit (primarily standby) outstanding with various financial institutions were approximately $87 million at March 29, 2014.
Commitments
On September 9, 2005, we completed a ten-year lease financing for a commercial facility located in Mentor, Ohio, used primarily for the North American headquarters and research center of our Materials group. The facility consists of land, buildings, and equipment. We lease the facility under an operating lease arrangement, which contains a residual value guarantee of $31.5 million, as well as certain obligations with respect to the refinancing of the lessors debt of $11.5 million (collectively, the Guarantee). At the end of the lease term, we have the option to purchase or remarket the facility at an amount equivalent to the value of the Guarantee. If our estimated fair value (or estimated selling price) of the facility falls below the Guarantee, we would be required to pay the lessor a shortfall, which is an amount equivalent to the Guarantee less our estimated fair value. During the second quarter of 2011, we estimated a shortfall with respect to the Guarantee and began to recognize the shortfall on a straight-line basis over the remaining lease term. The carrying amount of the shortfall was approximately $19 million at March 29, 2014, which was included in Long-term retirement benefits and other liabilities in the unaudited Condensed Consolidated Balance Sheets.
Avery Dennison Corporation
Note 16. Segment Information
Financial information by reportable segment from continuing operations is set forth below.
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales to unaffiliated customers |
|
|
|
|
| ||
Pressure-sensitive Materials |
|
$ |
1,143.5 |
|
$ |
1,098.0 |
|
Retail Branding and Information Solutions |
|
387.7 |
|
382.7 |
| ||
Vancive Medical Technologies |
|
18.9 |
|
18.2 |
| ||
Net sales to unaffiliated customers |
|
$ |
1,550.1 |
|
$ |
1,498.9 |
|
Intersegment sales |
|
|
|
|
| ||
Pressure-sensitive Materials |
|
$ |
16.2 |
|
$ |
16.5 |
|
Retail Branding and Information Solutions |
|
.8 |
|
.4 |
| ||
Vancive Medical Technologies |
|
2.3 |
|
.6 |
| ||
Intersegment sales |
|
$ |
19.3 |
|
$ |
17.5 |
|
Income from continuing operations before taxes |
|
|
|
|
| ||
Pressure-sensitive Materials |
|
$ |
112.0 |
|
$ |
104.9 |
|
Retail Branding and Information Solutions |
|
16.6 |
|
14.6 |
| ||
Vancive Medical Technologies |
|
(2.6 |
) |
(2.7 |
) | ||
Corporate expense |
|
(22.8 |
) |
(23.5 |
) | ||
Interest expense |
|
(15.4 |
) |
(12.2 |
) | ||
Income from continuing operations before taxes |
|
$ |
87.8 |
|
$ |
81.1 |
|
Other expense, net by reportable segment |
|
|
|
|
| ||
Pressure-sensitive Materials |
|
$ |
1.3 |
|
$ |
3.6 |
|
Retail Branding and Information Solutions |
|
6.0 |
|
3.0 |
| ||
Corporate |
|
|
|
.9 |
| ||
Other expense, net |
|
$ |
7.3 |
|
$ |
7.5 |
|
Other expense, net by type |
|
|
|
|
| ||
Restructuring costs: |
|
|
|
|
| ||
Severance and related costs |
|
$ |
7.0 |
|
$ |
6.8 |
|
Asset impairment charges |
|
.3 |
|
1.3 |
| ||
Other items: |
|
|
|
|
| ||
Gain on sale of assets |
|
|
|
(1.3 |
) | ||
Divestiture-related costs (1) |
|
|
|
.7 |
| ||
Other expense, net |
|
$ |
7.3 |
|
$ |
7.5 |
|
(1) Represents only the portion allocated to continuing operations.
Note 17. Recent Accounting Requirements
In April 2014, the Financial Accounting Standards Board (FASB) issued revised guidance on reporting discontinued operations. This revised guidance defines a discontinued operation as a disposal of a component or a group of components of an entity that represents a strategic shift that has (or will have) a major effect on the entitys operations and financial results. This revised guidance also requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This revised guidance is effective for fiscal years beginning on or after December 15, 2014 and interim periods within those years, with earlier adoption permitted. We do not anticipate the adoption of this revised guidance to have a significant impact on our financial position, results of operations, cash flows, or disclosures.
Avery Dennison Corporation
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Managements Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, provides managements views on our financial condition and results of operations, and should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and notes thereto. It includes the following sections:
17 | |
18 | |
20 | |
Results of Operations by Reportable Segment for the First Quarter |
21 |
23 | |
26 |
We report financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement presentation of our financial results that are prepared in accordance with GAAP. Based upon feedback from investors and financial analysts, we believe that supplemental non-GAAP financial measures provide information that is useful to the assessment of our performance and operating trends, as well as liquidity.
Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. By excluding certain accounting effects, both positive and negative, of certain items, we believe that we are providing meaningful supplemental information to facilitate an understanding of our core operating results and liquidity measures. These non-GAAP financial measures are used internally to evaluate trends in our underlying business, as well as to facilitate comparison to the results of competitors for a single period. While some of the items excluded from GAAP financial measures may recur, they tend to be disparate in amount, frequency, or timing.
We use the following non-GAAP financial measures in this MD&A:
· Organic sales change refers to the increase or decrease in sales excluding the estimated impact of currency translation, product line exits, acquisitions and divestitures, and, where applicable, the extra week in the fiscal year. The estimated impact of currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. We believe organic sales change assists investors in evaluating the underlying sales growth from the ongoing activities of our businesses and provides improved comparability of results period to period.
· Free cash flow refers to cash flow from operations, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sale of property, plant and equipment, plus (minus) net proceeds from sales (purchases) of investments, plus discretionary contributions to pension plans and charitable contribution to Avery Dennison Foundation utilizing proceeds from divestitures. Free cash flow excludes uses of cash that do not directly or immediately support the underlying business, such as discretionary debt reductions, dividends, share repurchases, and certain effects of acquisitions and divestitures (e.g., cash flow from discontinued operations, taxes, transaction costs).
· Operational working capital refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities, as well as current assets and current liabilities of held-for-sale businesses. We use this non-GAAP financial measure to assess our working capital (deficit) requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets, and other current liabilities) that tend to be disparate in amount, frequency, or timing, and that may increase the volatility of the working capital as a percentage of sales from period to period. Additionally, the excluded items are not significantly influenced by our day-to-day activities managed at the operating level and may not reflect the underlying trends in our operations.
Avery Dennison Corporation
Overview
Sales
Our sales increased 3% in the first three months of 2014 compared to the same period last year.
|
|
Three Months Ended |
| ||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
|
Estimated change in sales due to |
|
|
|
|
|
Organic sales change |
|
5 |
% |
4 |
% |
Foreign currency translation |
|
(1 |
) |
|
|
Reported sales change (1) |
|
3 |
% |
4 |
% |
(1) Totals may not sum due to rounding and other factors.
Income from Continuing Operations
Income from continuing operations increased approximately $5 million in the first three months of 2014 compared to the same period last year. Major factors affecting the change in income from continuing operations in the first three months of 2014 compared to the same period last year included:
Positive factors:
· Benefits from productivity initiatives, including savings from restructuring actions
· Higher volume
Offsetting factors:
· Higher employee-related costs
· Higher interest expense and provision for income taxes
· Foreign currency transaction net losses
· Raw material inflation
· Higher manufacturing expenses in North America, due in large part to extreme cold weather conditions during the quarter
Divestitures
In July 2013, we completed the sale of our former Office and Consumer Products (OCP) and Designed and Engineered Solutions (DES) businesses and entered into an amendment to the purchase agreement, which, among other things, increased the target net working capital amount and amended provisions related to employee matters and indemnification. We continue to be subject to certain indemnification provisions under the terms of the purchase agreement. In addition, the tax liability associated with the sale is subject to completion of tax return filings in the jurisdictions in which the OCP and DES businesses operated.
Cost Reduction Actions
2014 Actions
During the first three months of 2014, we recorded $7.3 million in restructuring charges, related to restructuring actions we initiated in 2014 (2014 Actions), consisting of severance and related costs for the reduction of approximately 340 positions and asset impairment charges. We anticipate approximately $8 million in annualized savings from these restructuring actions, of which approximately $6 million is expected to be realized in 2014, and the remainder in 2015.
2012 Program
In 2013, we recorded $40.3 million in restructuring charges, net of reversals, related to the restructuring program we initiated in 2012 (2012 Program), which consisted of severance and related costs for the reduction of approximately 1,400 positions, lease and other contract cancellation costs, and asset impairment charges.
In 2012, we recorded $56.4 million in restructuring charges, net of reversals, related to our 2012 Program, which consisted of severance and related costs for the reduction of approximately 1,060 positions, lease cancellation costs, and asset impairment charges.
Restructuring costs were included in Other expense, net in the unaudited Consolidated Statements of Income. Refer to Note 9, Cost Reduction Actions, to the unaudited Condensed Consolidated Financial Statements for more information.
Avery Dennison Corporation
Free Cash Flow
|
|
Three Months Ended | |||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net cash used by operating activities |
|
$ |
(108.0 |
) |
$ |
(65.7 |
) |
Purchases of property, plant and equipment |
|
(38.7 |
) |
(22.0 |
) | ||
Purchases of software and other deferred charges |
|
(8.9 |
) |
(7.8 |
) | ||
Proceeds from sale of property, plant and equipment |
|
.1 |
|
.9 |
| ||
Sale of investments, net |
|
.1 |
|
.1 |
| ||
Plus divestiture-related payments and free cash outflow from discontinued operations |
|
|
|
36.9 |
| ||
Free cash flow |
|
$ |
(155.4 |
) |
$ |
(57.6 |
) |
Free cash flow in the first three months of 2014 decreased compared to 2013 primarily due to the timing of collection of accounts receivable, longer payment terms with customers, and higher incentive compensation paid in 2014, partially offset by higher net income and lower pension contributions.
2014 Outlook
Certain factors that we believe may contribute to results for 2014 compared to results for 2013 are described below.
We expect organic sales growth of 3.5% to 5% in 2014.
The extra week in our 2014 fiscal year is anticipated to increase sales and have a modest positive impact on earnings.
We expect earnings to increase in 2014.
We estimate cash restructuring costs of approximately $45 million in 2014.
We expect our full year 2014 tax rate to be comparable to 2013.
We anticipate our capital and software expenditures in 2014 to be approximately $185 million.
Avery Dennison Corporation
ANALYSIS OF RESULTS OF OPERATIONS FOR THE FIRST QUARTER
Income from Continuing Operations before Taxes
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales |
|
$ |
1,550.1 |
|
$ |
1,498.9 |
|
Cost of products sold |
|
1,142.9 |
|
1,097.2 |
| ||
Gross profit |
|
407.2 |
|
401.7 |
| ||
Marketing, general and administrative expense |
|
296.7 |
|
300.9 |
| ||
Interest expense |
|
15.4 |
|
12.2 |
| ||
Other expense, net |
|
7.3 |
|
7.5 |
| ||
Income from continuing operations before taxes |
|
$ |
87.8 |
|
$ |
81.1 |
|
As a Percent of Sales |
|
|
|
|
| ||
Gross profit |
|
26.3 |
% |
26.8 |
% | ||
Marketing, general and administrative expense |
|
19.1 |
|
20.1 |
| ||
Income from continuing operations before taxes |
|
5.7 |
|
5.4 |
|
Sales
Sales from continuing operations increased 3% in the first quarter of 2014 compared to the same period last year, reflecting higher sales on an organic basis, partially offset by the unfavorable impact of foreign currency translation. On an organic basis, sales increased 5% due to higher volume.
Refer to Results of Operations by Reportable Segment for the First Quarter for further information.
Gross Profit Margin
Gross profit margin for the first quarter of 2014 decreased compared to the same period last year due to higher employee-related costs, changes in product mix, the impact of foreign currency transaction net losses, and modest impact of raw material inflation and pricing, partially offset by the benefits from productivity initiatives, including savings from restructuring.
Marketing, General and Administrative Expense
Marketing, general and administrative expense decreased in the first quarter of 2014 compared to the same period last year primarily due to the impact of higher savings from restructuring.
Other Expense, net
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Other expense, net by type |
|
|
|
|
| ||
Restructuring costs: |
|
|
|
|
| ||
Severance and related costs |
|
$ |
7.0 |
|
$ |
6.8 |
|
Asset impairment charges |
|
.3 |
|
1.3 |
| ||
Other items: |
|
|
|
|
| ||
Gain on sale of assets |
|
|
|
(1.3 |
) | ||
Divestiture-related costs(1) |
|
|
|
.7 |
| ||
Other expense, net |
|
$ |
7.3 |
|
$ |
7.5 |
|
(1) Represents only the portion allocated to continuing operations. |
Refer to Note 9, Cost Reduction Actions, to the unaudited Condensed Consolidated Financial Statements for more information regarding costs associated with restructuring.
Avery Dennison Corporation
Net Income and Earnings per Share
|
|
Three Months Ended |
| ||||
(In millions, except per share amounts) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Income from continuing operations before taxes |
|
$ |
87.8 |
|
$ |
81.1 |
|
Provision for income taxes |
|
16.2 |
|
14.3 |
| ||
Income from continuing operations |
|
71.6 |
|
66.8 |
| ||
Loss from discontinued operations, net of tax |
|
(.4 |
) |
(9.0 |
) | ||
Net income |
|
$ |
71.2 |
|
$ |
57.8 |
|
Net income per common share |
|
$ |
.74 |
|
$ |
.58 |
|
Net income per common share, assuming dilution |
|
|
.73 |
|
|
.57 |
|
|
|
|
|
|
| ||
Net income as a percent of sales |
|
4.6 |
% |
3.9 |
% | ||
Effective tax rate for continuing operations |
|
|
18.4 |
|
|
17.6 |
|
Provision for Income Taxes
The effective tax rate for continuing operations for the first quarter of 2014 included a discrete tax benefit of $9.5 million as a result of changes in certain tax reserves and valuation allowances and a $4.8 million benefit from out-of-period adjustments to properly state deferred taxes related to acquisitions completed in 2002 and 2003. The effective tax rate for the first quarter of 2013 reflected discrete tax benefits of $10.3 million related to changes in tax law, including a $4.2 million benefit attributable to the retroactive reinstatement of the federal research and development tax credit and a $5.1 million benefit for revaluation of deferred tax balances due to a change in the municipal statutory tax rate in Luxembourg. Refer to Note 11, Taxes Based on Income, to the unaudited Condensed Consolidated Financial Statements for further information.
Our effective tax rate can vary widely from quarter to quarter, resulting from interim reporting requirements, the recognition of discrete events and the timing of repatriation of foreign earnings.
RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE FIRST QUARTER
Operating income refers to income from continuing operations before interest and taxes.
Pressure-sensitive Materials
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales including intersegment sales |
|
$ |
1,159.7 |
|
$ |
1,114.5 |
|
Less intersegment sales |
|
(16.2 |
) |
(16.5 |
) | ||
Net sales |
|
$ |
1,143.5 |
|
$ |
1,098.0 |
|
Operating income (1) |
|
112.0 |
|
104.9 |
| ||
(1) Included costs associated with restructuring in both quarters |
|
$ |
1.3 |
|
$ |
3.6 |
|
Net Sales
In the first quarter of 2014, sales in our Pressure-sensitive Materials segment increased approximately 4% compared to the same period last year, reflecting higher sales on an organic basis, partially offset by the unfavorable impact of foreign currency translation. On an organic basis, sales increased 6% due to higher volume. On an organic basis, sales increased 10% in emerging markets, at a mid-single digit rate in Western Europe, and slightly in North America.
In our label and packaging materials business, sales on an organic basis increased in the three months ended March 29, 2014 at a mid-single digit rate. Combined sales on an organic basis for our graphics, reflective, and performance tapes businesses also increased in the three months ended March 29, 2014 at a mid-single digit rate.
Operating Income
Operating income increased in the first quarter of 2014 compared to the same period last year primarily reflecting higher volume, the benefits from productivity initiatives, including savings from restructuring, as well as lower restructuring costs, partially offset by higher employee-related costs, modest impact of raw material inflation and pricing, the impact of foreign currency transaction net losses, and higher manufacturing expenses in North America, due in large part to extreme cold weather conditions during the quarter.
Avery Dennison Corporation
Retail Branding and Information Solutions
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales including intersegment sales |
|
$ |
388.5 |
|
$ |
383.1 |
|
Less intersegment sales |
|
(.8 |
) |
(.4 |
) | ||
Net sales |
|
$ |
387.7 |
|
$ |
382.7 |
|
Operating income (1) |
|
16.6 |
|
14.6 |
| ||
(1) Included costs associated with restructuring in both quarters, and gain on sale of assets in 2013 |
|
$ |
6.0 |
|
$ |
3.0 |
|
Net Sales
In the first quarter of 2014, sales in our Retail Branding and Information Solutions segment increased approximately 1% compared to the same period last year, reflecting higher sales on an organic basis, partially offset by the unfavorable impact of foreign currency translation. On an organic basis, sales grew approximately 2% primarily due to higher volume from increased demand from Europe-based retailers and brands.
Operating Income
Operating income increased in first quarter of 2014 primarily reflecting savings from restructuring and higher volume, partially offset by higher employee-related costs, higher restructuring costs, and the impact of a gain on sale of assets in the same period last year.
Vancive Medical Technologies
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net sales including intersegment sales |
|
$ |
21.2 |
|
$ |
18.8 |
|
Less intersegment sales |
|
(2.3 |
) |
(.6 |
) | ||
Net sales |
|
$ |
18.9 |
|
$ |
18.2 |
|
Operating loss |
|
(2.6 |
) |
(2.7 |
) |
Net Sales
In the first quarter of 2014, sales in our Vancive Medical Technologies segment increased approximately 4% compared to the same period last year, reflecting higher sales on an organic basis and the favorable effect of foreign currency translation. On an organic basis, sales increased approximately 2% due to higher volume.
Operating Loss
Operating loss in the first quarter of 2014 was comparable to the same period last year.
Avery Dennison Corporation
Liquidity
Cash Flow from Operating Activities
|
|
Three Months Ended | |||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net income |
|
$ |
71.2 |
|
$ |
57.8 |
|
Depreciation and amortization |
|
50.0 |
|
51.5 |
| ||
Provision for doubtful accounts and sales returns |
|
7.3 |
|
5.5 |
| ||
Net loss from asset impairments and sale/disposal of assets |
|
.8 |
|
.4 |
| ||
Stock-based compensation |
|
6.0 |
|
9.2 |
| ||
Other non-cash items |
|
11.8 |
|
14.7 |
| ||
Change in assets and liabilities and other adjustments |
|
(255.1 |
) |
(204.8 |
) | ||
Net cash used in operating activities |
|
$ |
(108.0 |
) |
$ |
(65.7 |
) |
For cash flow purposes, changes in assets and liabilities and other adjustments exclude the impact of foreign currency translation (discussed below in Analysis of Selected Balance Sheet Accounts).
During the first three months of 2014, cash flow used in operating activities increased compared to the same period last year due to the timing of collection of accounts receivable, longer payment terms with customers, and higher incentive compensation paid in 2014. These factors were partially offset by the impact of cash outflow related to the OCP and DES businesses in the prior year, as well as higher net income and lower pension contributions in the current year.
Cash Flow from Investing Activities
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Purchases of property, plant and equipment |
|
$ |
(38.7 |
) |
$ |
(22.0 |
) |
Purchases of software and other deferred charges |
|
(8.9 |
) |
(7.8 |
) | ||
Proceeds from sale of property, plant and equipment |
|
.1 |
|
.9 |
| ||
Sales of investments, net |
|
.1 |
|
.1 |
| ||
Net cash used in investing activities |
|
$ |
(47.4 |
) |
$ |
(28.8 |
) |
Capital and Software Spending
During the first three months of 2014, we invested in new equipment primarily in Asia, the U.S. and Europe. During the first three months of 2013, we invested in new equipment primarily in the U.S. and Asia.
Information technology investments in the first three months of both 2014 and 2013 were primarily associated with standardization initiatives.
Cash Flow from Financing Activities
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Net change in borrowings and payments of debt |
|
$ |
90.0 |
|
$ |
134.8 |
|
Dividends paid |
|
(27.8 |
) |
(27.1 |
) | ||
Share repurchases |
|
(59.2 |
) |
(61.8 |
) | ||
Proceeds from exercise of stock options, net |
|
12.5 |
|
26.4 |
| ||
Other |
|
(3.2 |
) |
(6.2 |
) | ||
Net cash provided by financing activities |
|
$ |
12.3 |
|
$ |
66.1 |
|
Borrowings and Repayment of Debt
During the first three months of 2014 and 2013, our commercial paper and foreign short-term borrowings were used mainly to fund share repurchase activity (given the seasonality of our cash flow during the year) and support operational requirements. Refer to Share Repurchases below for more information.
Dividend Payments
Our dividend per share was $.29 in the first quarter of 2014 compared to $.27 per share in the same period last year.
Avery Dennison Corporation
On April 24, 2014, subsequent to the end of the first quarter of 2014, we increased our quarterly dividend to $.35 per share, representing a 21% increase from our previous dividend rate of $.29 per share.
Share Repurchases
During the first three months of 2014, we repurchased approximately 1.2 million shares of our common stock at an aggregate cost of $59.2 million. During the first three months of 2013, we repurchased approximately 1.5 million shares of our common stock at an aggregate cost of $61.8 million.
As of March 29, 2014, shares of our common stock in the aggregate amount of approximately $396 million remained authorized for repurchase under our July 2013 Board authorization.
Analysis of Selected Balance Sheet Accounts
Long-lived Assets
In the three months ended March 29, 2014, goodwill increased by approximately $9 million to $760 million, which reflected the impact of acquisition adjustments and foreign currency translation.
In the three months ended March 29, 2014, other intangibles resulting from business acquisitions, net, decreased by approximately $6 million to $90 million, which primarily reflected current year amortization expense.
Refer to Note 4, Goodwill and Other Intangibles Resulting from Business Acquisitions, to the unaudited Condensed Consolidated Financial Statements for more information.
In the three months ended March 29, 2014, other assets increased by approximately $2 million to $488 million, which reflected increases in the cash surrender value of our corporate-owned life insurance and software and other deferred charges net of amortization, partially offset by the collection of a long-term value-added tax receivable in Europe.
Shareholders Equity Accounts
In the three months ended March 29, 2014, the balance of our shareholders equity increased by approximately $3 million to $1.5 billion, which primarily reflected the effect of net income, partially offset by share repurchases and dividend payments.
In the three months ended March 29, 2014, the balance of our treasury stock increased by approximately $35 million to $1.21 billion, which reflected share repurchase activity, partially offset by the use of treasury shares to settle exercises of stock options and releases of stock-based awards and the funding of contributions to our U.S. defined contribution plan.
Impact of Foreign Currency Translation
|
|
Three Months Ended |
| ||||
(In millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
Change in net sales |
|
$ |
(18 |
) |
$ |
3 |
|
Change in income from continuing operations |
|
|
|
1 |
| ||
International operations generated approximately 76% of our net sales during the three months ended March 29, 2014. Our future results are subject to changes in political and economic conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.
The effect of foreign currency translation on net sales in the first three months of 2014 compared to the same period last year primarily reflected the unfavorable impact from sales in Brazil, India, Australia, and Argentina, partially offset by the favorable impact from sales in the European Union and China.
Effect of Foreign Currency Transactions
The impact on net income from transactions denominated in foreign currencies may be mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate.
Analysis of Selected Financial Ratios
We utilize the financial ratios discussed below to assess our financial condition and operating performance.
Avery Dennison Corporation
Working Capital (Deficit) and Operational Working Capital Ratios
Working capital (deficit) (current assets minus current liabilities and net assets held for sale), as a percent of annualized net sales, increased in the first three months of 2014 compared to the same period last year, primarily due to a decrease in short-term and current portion of long-term debt, as well as an increase in net trade accounts receivable and inventories.
Operational working capital, as a percent of annualized net sales, is reconciled with working capital (deficit) below. Our objective is to minimize our investment in operational working capital, as a percentage of sales, to maximize cash flow and return on investment.
|
|
Three Months Ended |
| ||||
(Dollars in millions) |
|
March 29, 2014 |
|
March 30, 2013 |
| ||
(A) Working capital (deficit) |
|
$ |
531.2 |
|
$ |
(24.0 |
) |
Reconciling items: |
|
|
|
|
| ||
Cash and cash equivalents |
|
(205.1 |
) |
(207.7 |
) | ||
Current deferred and refundable income taxes and other current assets |
|
(232.8 |
) |
(249.6 |
) | ||
Short-term borrowings and current portion of long-term debt and capital leases |
|
167.9 |
|
655.4 |
| ||
Current deferred and payable income taxes and other current accrued liabilities |
|
485.3 |
|
517.7 |
| ||
(B) Operational working capital |
|
$ |
746.5 |
|
$ |
691.8 |
|
(C) Annualized net sales (quarter sales, multiplied by four) |
|
$ |
6,200.4 |
|
$ |
5,995.6 |
|
Working capital (deficit), as a percent of annualized net sales (A) ÷ (C) |
|
8.6 |
% |
(.4 |
)% | ||
Operational working capital, as a percent of annualized net sales (B) ÷ (C) |
|
12.0 |
% |
11.5 |
% |
As a percent of annualized sales, operational working capital for the first three months of 2014 increased compared to the same period in the prior year. The primary factors contributing to this change, which include the impact of foreign currency translation, are discussed below.
Accounts Receivable Ratio
The average number of days sales outstanding was 64 days in the first three months of 2014 compared to 60 days in the first three months of 2013, calculated using the trade accounts receivable balance at quarter-end divided by the average daily sales for the quarter. The increase in current year average number of days sales outstanding reflected the timing of collection and longer payment terms with customers.
Inventory Ratio
Average inventory turnover was 8.3 in the first three months of 2014 compared to 8.5 in the first three months of 2013, calculated using the annualized cost of sales (quarterly cost of sales, multiplied by four) divided by the inventory balance at quarter-end. The decrease in the average inventory turnover from the prior year primarily reflected increased production volume.
Accounts Payable Ratio
The average number of days payable outstanding was 70 days in the first three months of 2014 compared to 67 days in the first three months of 2013, calculated using the accounts payable balance at quarter-end divided by the average daily cost of products sold for the quarter. The increase in the average number of days payable outstanding from prior year was primarily due to the impact of extensions in payment terms with suppliers and the timing of inventory purchases.
Capital Resources
Capital resources include cash flows from operations, cash and cash equivalents and debt financing. At March 29, 2014, we had cash and cash equivalents of approximately $205 million held in accounts at third-party financial institutions.
Our cash balances are held in numerous locations throughout the world. At March 29, 2014, the majority of our cash and cash equivalents were held by our foreign subsidiaries. To meet U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating certain foreign earnings. However, if we were to repatriate incremental foreign earnings, we may be subject to additional taxes in the U.S.
Our $675 million revolving credit facility (the Revolver), which supports our commercial paper program, matures on December 22, 2016. Based upon our current outlook for our business and market conditions, we believe that the Revolver, in addition to the uncommitted bank lines of credit maintained in the countries in which we operate, would, if necessary, provide sufficient liquidity to fund our operations during the next twelve months. As of March 29, 2014, no balances were outstanding under the Revolver.
Avery Dennison Corporation
We are exposed to financial market risk resulting from changes in interest and foreign currency rates, and to possible liquidity and credit risks of our counterparties.
Capital from Debt
Our total debt increased by approximately $90 million in the first three months of 2014 to $1.12 billion compared to $1.03 billion at year-end 2013, primarily reflecting an increase in commercial paper and foreign short-term borrowings to fund share repurchase activity (given the seasonality of our cash flow during the year) and support operational requirements.
Credit ratings are a significant factor in our ability to raise short-term and long-term financing. The credit ratings assigned to us also impact the interest rates paid and our access to commercial paper, credit facilities, and other borrowings. A downgrade of our short-term credit ratings below our current levels could impact our ability to access the commercial paper markets. If our access to commercial paper markets were to become limited, the Revolver and our other credit facilities would be available to meet our short-term funding requirements, if necessary. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to retaining an investment grade rating.
Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters
Refer to Note 15, Commitments and Contingencies, to the unaudited Condensed Consolidated Financial Statements.
RECENT ACCOUNTING REQUIREMENTS
Refer to Note 17, Recent Accounting Requirements, to the unaudited Condensed Consolidated Financial Statements.
Avery Dennison Corporation
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 28, 2013.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (SEC), and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.
Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Glendale, California. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.
Changes in Internal Control Over Financial Reporting
We periodically assesses our overall control environment, including the control environment of acquired businesses.
During the third quarter of 2013, we began a phased implementation of a new financial system, primarily for our North American and European pressure-sensitive materials businesses, medical solutions business and our corporate accounting function. At the same time, we commenced a phased outsourcing of transaction processing and accounting activities to a new third-party service provider. As part of the transition process, we reviewed the related internal controls and determined that the design of the controls surrounding these processes satisfied our control objectives. Where appropriate, we made changes to affected internal controls and are in the process of testing their operating effectiveness. We are performing the implementation in the ordinary course of business to increase efficiency and we expect to continue the implementation over the next several quarters.
Except for these changes, there has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Avery Dennison Corporation
Refer to Legal Proceedings in Note 15, Commitments and Contingencies, to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1.
There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 28, 2013.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a) Not Applicable
(b) Not Applicable
(c) Repurchases of Equity Securities by Issuer
Repurchases by us or our affiliated purchasers (as defined in Rule 10b-18(a)(3) of the Securities Exchange Act of 1934) of registered equity securities in the three fiscal months of the first quarter of 2014 are listed in the following table.
(Dollars in millions, except per share amounts; |
|
Total Number of |
|
Average |
|
Total Number of |
|
Approximate |
| ||
December 29, 2013 January 25, 2014 |
|
142.0 |
|
$ |
50.33 |
|
142.0 |
|
|
| |
January 26, 2014 February 22, 2014 |
|
373.8 |
|
|
48.48 |
|
373.8 |
|
|
| |
February 23, 2014 March 29, 2014 |
|
674.8 |
|
|
50.26 |
|
674.8 |
|
|
| |
Total |
|
1,190.6 |
|
$ |
49.71 |
|
1,190.6 |
|
$ |
395.8 |
|
Repurchased shares may be reissued under our stock option and incentive plan or used for other corporate purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not Applicable
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable
Avery Dennison Corporation
Not Applicable
Exhibit 12* |
|
Computation of Ratio of Earnings to Fixed Charges |
Exhibit 31.1* |
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
Exhibit 31.2* |
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
Exhibit 32.1** |
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
Exhibit 32.2** |
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
Exhibit 101.INS |
|
XBRL Instance Document |
Exhibit 101.SCH |
|
XBRL Extension Schema Document |
Exhibit 101.CAL |
|
XBRL Extension Calculation Linkbase Document |
Exhibit 101.LAB |
|
XBRL Extension Label Linkbase Document |
Exhibit 101.PRE |
|
XBRL Extension Presentation Linkbase Document |
Exhibit 101.DEF |
|
XBRL Extension Definition Linkbase Document |
* Filed herewith.
** Furnished herewith.
Avery Dennison Corporation
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
AVERY DENNISON CORPORATION |
|
(Registrant) |
|
|
|
|
|
|
|
|
|
/s/ Mitchell R. Butier |
|
Mitchell R. Butier |
|
Senior Vice President and |
|
Chief Financial Officer |
|
(Principal Financial Officer) |
|
|
|
|
|
|
|
/s/ Lori J. Bondar |
|
Lori J. Bondar |
|
Vice President, Controller, and |
|
Chief Accounting Officer |
|
(Principal Accounting Officer) |
|
|
|
|
|
|
|
May 5, 2014 |